Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting m6A-SCG2-TAMs axis overcomes 5-FU resistance in colorectal cancer via a multi-omics model.

NPJ digital medicine·2026
Same author

Modulating proton-coupled electron transfer in 2D metal-covalent organic frameworks for garnering meliorated dual-function photocatalysis.

Journal of colloid and interface science·2026
Same author

A durable solution for challenging multidrug-resistant bone infections: a retrospective study on long-term efficacy of the flow-through fibula osteocutaneous flap in limb reconstruction.

BMC surgery·2026
Same author

Systematic Construction of Type-II BiVO<sub>4</sub>/CoWO<sub>4</sub> p-n Heterojunction Photoanodes for Efficient Photoelectrochemical Water Splitting.

ChemSusChem·2026
Same author

CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management.

International journal of nanomedicine·2026
Same author

CRISPR-Cas9-mediated homology-directed repair rescues the induced bone marrow failure in <i>Fancc</i> <sup>-/-</sup> mice.

Molecular therapy. Nucleic acids·2026

Related Experiment Video

Updated: Jun 21, 2026

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
09:12

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol

Published on: April 5, 2024

[Trends in development of self-complementary adeno-associated virus vector].

Yinghui Lü1, Qizhao Wang, Weidong Xiao

  • 1Institute of Molecular Medicine, Huaqiao University, Fujian 362021, China.

Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|August 13, 2009
PubMed
Summary

Self-complementary adeno-associated viral vectors (scrAAV) enhance gene therapy efficiency by packaging double-stranded DNA, bypassing a critical viral step. This approach shows promise for treating genetic disorders like Hemophilia B.

More Related Videos

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
06:41

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors

Published on: October 20, 2023

Related Experiment Videos

Last Updated: Jun 21, 2026

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
09:12

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol

Published on: April 5, 2024

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
06:41

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors

Published on: October 20, 2023

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Context:

  • Recombinant adeno-associated virus (AAV) vectors are effective for gene delivery but require single-stranded DNA conversion, limiting efficiency.
  • Self-complementary AAV (scrAAV) vectors package an inverted repeat genome that forms double-stranded DNA without host cell synthesis.

Purpose:

  • To review the preparation, expression, and in vitro/in vivo location of scrAAV.
  • To highlight recent advancements in scrAAV-based gene therapy for Hemophilia B.
  • To elucidate the potential and prospects of scrAAV in broader gene therapy applications.

Summary:

  • scrAAV vectors circumvent the need for intracellular DNA conversion, leading to increased expression efficiency.
  • This method reduces vector-induced immune responses, enhancing safety and therapeutic outcomes.
  • scrAAV has demonstrated utility in treating hepatic, central nervous system, and ocular diseases, as well as in stem cell modification and as siRNA/miRNA/ribozyme vectors.

Impact:

  • scrAAV represents a significant advancement in gene therapy vector design, offering improved efficacy and safety.
  • Its application in treating genetic disorders like Hemophilia B showcases its therapeutic potential.
  • Further research into scrAAV vectors could expand their use across various inherited diseases.